You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A Preclinical Trial of Therapeutic Angiogenesis Plus Angioplasty and Stenting for Renal Vascular Disease
SBC: LEFLORE TECHNOLOGIES LLC Topic: 400Abstract Chronic kidney disease CKD is a progressive disorder affecting almost of the general population and this disease has shown a relentless growth over the past decades Patients with CKD have higher rates of hospitalization greater mortality shorter life expectancy and their healthcare costs are up to times more expensive than non CKD patients Thus treatments to slow halt ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Biocatalytic production of precursors to lutein and zeaxanthin to address age related macular degeneration
SBC: EscaZyme Biochemicals, LLC Topic: NProject Summary Atrophic dry age related macular degeneration AMD is the leading cause of severe loss of vision for those over age Dietary supplements containing lutein and zeaxanthin are recommended by the NEI for those at risk of late AMD There has been a corresponding growth in demand for these two xanthophylls Lutein and zeaxanthin are currently sourced from marigolds grown mostl ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Developing Testing and Validating a Wearable Alcohol Biosensor
SBC: Clinitech, LLC Topic: 450PROJECT SUMMARY This application for a Phase I SBIR award represents a collaboration between Clinitech LLC and McLean Hospital Harvard Medical School to develop a wearable biosensor for detecting alcohol in the interstitial fluid of humans who have consumed alcohol Excessive use of alcohol accounts for much of the public health burden related to alcohol use disorders including fetal ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Synthesis of HAN and HEHN in a Continuous Mix Process
SBC: Digital Solid State Propulsion, Inc Topic: AF171061Production of hydroxylamine nitrate (HAN) and hydroxyethyl hydrazine nitrate (HEHN) is of great concern for the manufacture of AF-315E. Current stockpiles of heritage ingredients held by AFRL are being depleted and those manufacturers are no longer in exi
SBIR Phase I 2017 Department of DefenseAir Force -
High Voltage (HV) Fireset Systems and Subsystem Component Level Designs
SBC: HYPERION TECHNOLOGY GROUP INC Topic: AF171089Current and future explosive munition weapon systems development relies heavily on explosives detonation performance characterization and computational hydro-code simulation research conducted by DoD and DoE research communities. This work in turn relies
SBIR Phase I 2017 Department of DefenseAir Force -
Prediction and Measurement of the Soot Build-Up in Film-Cooled Rocket Engines
SBC: SIERRA ENGINEERING, INC. Topic: AF15AT21This Phase II STTR effort is focused on generating the data necessary to identify the phenomenology that produces carbon deposition within kerosene film cooled rocket engines.This data is essential to guide the model development and validation process.Program outputs will be both data and a physics-based model for carbon deposition.
STTR Phase II 2017 Department of DefenseAir Force -
Thermally Targeted Delivery of Therapeutic Peptides
SBC: Thermally Targeted Therapeutics, Incorporated Topic: N/ADESCRIPTION (provided by applicant): Current treatment of solid tumors is limited by normal tissue tolerance, inherent tumor resistance to radiation or chemotherapy, and toxicity from systemic administration of antineoplastic agents. The result is a narrow therapeutic index for most current chemotherapeutic agents. Our long term goal is to overcome these limitations by developing a targeted therap ...
SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health -
Compositions for Prevention/Prophylactic Treatment of Poison Ivy Dermatitis
SBC: ElSohly Laboratories, Incorporated Topic: N/ADESCRIPTION (provided by applicant): Poison ivy/oak contact dermatitis is the most prevalent skin allergy in the United States, affecting gt50% of the adult population. The condition is the major cause of occupational hazard among outdoor workers in forestry, agriculture and firefighting, resulting in significant medical expenses and workers disability. Attempts have been made to provide prophyla ...
STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health -
Method of Locating Unexploded Ordnance
SBC: MAV6 Topic: AF083236The Unexploded Ordnance Asset RFID System (UARS) is an active low frequency RFID tracking system designed for locating unexploded ordinance (UXO) on the battlefield. The system is a passive thin collar RFID tag that is placed onto the munition during manufacture and becomes activated after delivery on target. Once activated, the RFID tag enters a passive listening mode, waiting for a specific ...
SBIR Phase I 2009 Department of DefenseAir Force -
Replacement for Hexavalent Chromium Conversion Coatings for Magnesium and Zinc-Nickel
SBC: METALAST INTERNATIONAL, INC. Topic: AF083226The European Union''s RoHS and WEE Directives mandated the elimination of the carcinogenic, hexavalent chromium coatings for metals, including magnesium and zinc-nickel plated substrates. The purpose of this project is to find chemistry that will meet requirements of industry performance specifications and of the mandate. METALAST intends to explore trivalent chromium in conjunction with two o ...
SBIR Phase I 2009 Department of DefenseAir Force